Skip to main content

Burrows Scott L's Form 4 filing

Spyre Therapeutics, Inc. (SYRE) · filed Sep 3, 2026

Accession no.
0001636282-26-000109
Filed
Sep 3, 2026, 9:33 PM ET
Trade date
Sep 1-2, 2026
Filing delay
2 days
Rule 10b5-1 plan
Checked

This filing lists 6 non-derivative transactions and 1 derivative transaction. Open-market sales total $2.28M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Burrows Scott LCIK 0001853327Officer (Chief Financial Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Sep 1, 2026Common StockMOption exerciseAcquired+7,500$14.50+$108,750105,494Direct
Sep 1, 2026Common StockSSaleDisposed−900$86.25−$77,625104,594Direct
Sep 1, 2026Common StockSSaleDisposed−4,384$87.11−$381,890.24100,210Direct
Sep 1, 2026Common StockSSaleDisposed−2,016$88.03−$177,468.4898,194Direct
Sep 1, 2026Common StockSSaleDisposed−200$89.04−$17,80897,994Direct
Sep 2, 2026Common StockSSaleDisposed−18,232$89.35−$1,629,029.279,762Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Sep 1, 2026Common StockMOption exerciseDisposed−7,500$0.00$0337,357Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)